Literature DB >> 13580282

Experimental coronary arterial occlusion: effects of the administration of oxygen under pressure.

G SMITH, D A LAWSON.   

Abstract

Entities:  

Keywords:  CORONARY DISEASE/experimental; OXYGEN/effects

Mesh:

Substances:

Year:  1958        PMID: 13580282     DOI: 10.1177/003693305800300803

Source DB:  PubMed          Journal:  Scott Med J        ISSN: 0036-9330            Impact factor:   0.729


× No keyword cloud information.
  10 in total

1.  THE PRESENT POSITION OF HYPERBARIC OXYGEN THERAPY.

Authors:  G SMITH
Journal:  Proc R Soc Med       Date:  1964-09

2.  A life in new drug research.

Authors:  James Black
Journal:  Br J Clin Pharmacol       Date:  2010-09       Impact factor: 4.335

3.  A life in new drug research.

Authors:  James Black
Journal:  Br J Pharmacol       Date:  2010-07       Impact factor: 8.739

4.  Proceedings of the british cardiac society.

Authors: 
Journal:  Br Heart J       Date:  1966-11

5.  The Intensive Care of the Coronary Crisis.

Authors:  A J Cameron
Journal:  Proc R Soc Med       Date:  1965-02

6.  Controlled trial of oxygen in uncomplicated myocardial infarction.

Authors:  J M Rawles; A C Kenmure
Journal:  Br Med J       Date:  1976-05-08

7.  Nobel lecture in physiology or medicine--1988. Drugs from emasculated hormones: the principle of syntopic antagonism.

Authors:  J Black
Journal:  In Vitro Cell Dev Biol       Date:  1989-04

8.  Severe acute myocardial infarction treated with hyperbaric oxygen. Report on forty patients.

Authors:  R Ashfield; C J Gavey
Journal:  Postgrad Med J       Date:  1969-10       Impact factor: 2.401

Review 9.  Hyperbaric oxygen therapy for acute coronary syndrome.

Authors:  Michael H Bennett; Jan P Lehm; Nigel Jepson
Journal:  Cochrane Database Syst Rev       Date:  2015-07-23

Review 10.  Intracoronary Application of Super-Saturated Oxygen to Reduce Infarct Size Following Myocardial Infarction.

Authors:  Andreas Schäfer; Muharrem Akin; Johanna Diekmann; Tobias König
Journal:  J Clin Med       Date:  2022-03-09       Impact factor: 4.241

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.